Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene

Lobular carcinoma in situ (LCIS) is an unusual histological pattern of non-invasive neoplastic disease of the breast occurring predominantly in women aged between 40 and 50 years. LCIS is frequently multicentric and bilateral, and there is evidence that it is associated with an elevated familial risk of breast cancer. Although women with LCIS suffer an increased risk of invasive breast disease, this risk is moderate suggesting that LCIS may result from mutation of a gene or genes conferring a high risk of LCIS, but a lower risk of invasive breast cancer. The high frequency of somatic mutations in E-cadherin in LCIS, coupled with recent reports that germline mutations in this gene can predispose to diffuse gastric cancer, raised the possibility that constitutional E-cadherin mutations may confer susceptibility to LCIS. In order to explore this possibility we have examined a series of 65 LCIS patients for germline E-cadherin mutations. Four polymorphisms were detected but no pathogenic mutations were identified. The results indicate that E-cadherin is unlikely to act as a susceptibility gene for LCIS. © 2000 Cancer Research Campaign

[1]  H. Höfler,et al.  Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. , 1999, The American journal of pathology.

[2]  Kylie L. Gorringe,et al.  Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. , 1998, Cancer research.

[3]  Anthony E. Reeve,et al.  E-cadherin germline mutations in familial gastric cancer , 1998, Nature.

[4]  Heinz Höfler,et al.  Mutations of the human E‐cadherin (CDH1) gene , 1998, Human mutation.

[5]  M. J. van de Vijver,et al.  Simultaneous loss of E‐cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ , 1997, The Journal of pathology.

[6]  M. Stratton Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases , 1997, The Lancet.

[7]  C. la Vecchia,et al.  Trends of in situ carcinoma of the breast in Vaud, Switzerland. , 1997, European journal of cancer.

[8]  M. J. van de Vijver,et al.  © 1997 Cancer Research Campaign , 2022 .

[9]  G. Berx,et al.  E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. , 1996, Oncogene.

[10]  R. Goldschmidt,et al.  Lobular carcinoma in situ of the breast. , 1996, Seminars in surgical oncology.

[11]  M. Vijver,et al.  E‐cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. , 1995, The EMBO journal.

[12]  M. Stratton,et al.  Loss of heterozygosity in lobular carcinoma in situ of the breast , 1995, Clinical molecular pathology.

[13]  M. Takeichi Morphogenetic roles of classic cadherins. , 1995, Current opinion in cell biology.

[14]  M H Skolnick,et al.  Familiality of cancer in Utah. , 1994, Cancer research.

[15]  W. Birchmeier,et al.  Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. , 1993, The American journal of pathology.

[16]  D J Prockop,et al.  Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[17]  K. Zedeler,et al.  Lobular carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. The Danish Breast Cancer Cooperative Group. , 1992, The American journal of surgical pathology.

[18]  W. Thompson,et al.  Relationship between breast histopathology and family history of breast cancer , 1993, Cancer.

[19]  K. Zedeler,et al.  Lobular Carcinoma In Situ of the Female Breast , 1992 .

[20]  W. Dupont,et al.  Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. , 1991, Human pathology.

[21]  R. Hutter,et al.  Lobular carcinoma in situ of the breast: clinical, pathologic, and mammographic features. , 1991, AJR. American journal of roentgenology.

[22]  C. Key,et al.  Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study , 1987, Cancer.

[23]  F. Santiago,et al.  Lobular carcinoma in situ of the breast. , 1987, Surgery, gynecology & obstetrics.

[24]  F. W. Foote,et al.  Classics in oncology: Lobular carcinoma in situ: A rare form of mammary cancer , 1982 .